The Bavarian Pharmagipfel aims to create with its partners a sustainable and financially viable healthcare system that promotes progress and patient orientation in medicine and enables access to innovative diagnostics and therapy, including digital innovations, for all patients.
The Bavarian Pharma Summit 2024 took place in Munich on July 29, 2024. This continues the open dialog between the Bavarian state government and the pharmaceutical industry.
The Joint Declaration presented there by pharmaceutical associations and manufacturers sets out targeted measures and demands to maintain and strengthen pharmaceutical production with the following points
The Bavarian state government has been in intensive dialog with the pharmaceutical industry since 2015. With the measures developed by the Bavarian Ministry of Economic Affairs, the Bavarian Ministry of Health and the pharmaceutical industry as part of the Bavarian Pharmagipfel in 2015 and 2019, Bavaria has provided decisive impetus in recent years for measures at the federal level to ensure the security of supply of medicines.
Following an update of the Joint Declaration in 2021, the Bavarian Ministry of Economic Affairs and Ministry of Health developed three papers together with representatives of the pharmaceutical industry and other stakeholders from the healthcare sector. These were published and discussed at the Bavarian Pharmagipfel 2023 in Berlin on April 19, 2023 (in German only):
Photo: The presentation of the Joint Declaration at the Bavarian Pharma Summit 2024. © StMWi
Joint Declaration of the "Bavarian Pharmagipfel conference" of July 29, 2024 (pdf)
